Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5859 posts found.

top_10_image

Top Ten most popular articles on Pharmafile.com this week!

May 3, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, Gilead, autism, dementia, opioids, pharma

This week was marked by the failure of two Phase 3 trials after both Eli Lilly and Gilead suffered from …
News

Takeda opens R&D facility in San Diego, California

May 2, 2019 Manufacturing and Production, Research and Development CNS, GI, Japan, Takeda, california, neuroscience, san diego

Japanese-firm Takeda pharmaceuticals has opened a new research facility in San Diego, California. The 165,000ft2 research centre will employ 250 …
News
robin_washington

Gilead’s CFO and Executive Vice President to depart in 2020

May 1, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, appointment, pharma

Gilead has announced that Robin Washington, the company’s Senior Vice President and Chief Financial Officer of more than a decade, …
News
gsk_boronia_australia

GSK’s Benlysta becomes first FDA-approved IV therapy for paediatric lupus

April 30, 2019 Manufacturing and Production, Sales and Marketing Benlysta, FDA, GSK, Lupus, US, pharma

GSK has scored approval in the US with Benlysta (belimumab) for the treatment of systemic lupus erythematosus (SLE) in paediatric …
News

Two thirds of MPs believe NHS should spend less on medicines

April 30, 2019 Manufacturing and Production Long Term Plan, MPs, NHS, UK, government, health, public health

Nearly two thirds (64%) of MPs believe the NHS should direct more resources towards prevention, over funding for new treatments, …
News
donald_trump-_image_credit_gage_skidmore

Donald Trump says he will not accept campaign money from pharma

April 30, 2019 Manufacturing and Production Donald Trump, USA, campaign contributionss, pharma, politics

President Donald Trump has said he will not accept money from pharmaceutical companies in the run up to the 2020 …
News

New Phase 3 data confirms safety and efficacy of UCB’s Cimzia in plaque and psoriatic arthritis

April 30, 2019 Manufacturing and Production, Research and Development Cimzia, UCB Pharma, pharma, plaque psoriasis, psoriasis

New Phase 3 data has been released by UCB Pharma on the safety of Cimzia (certolizumab pegol) in the treatment …
News
482px-sem_blood_cells

Stanford scientists develop test for ME

April 30, 2019 Manufacturing and Production CFS, ME, diagnosis, electric curernt, immune system, nanoelectronic assay

Scientists from Stanford University have, for the first time, developed a test for Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). The blood …
News

The price of access: Can the NHS afford Orkambi?

April 29, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Drug pricing, NHS, NICE, Orkambi, UK, Vertex, access, cystic fibrosis, feature, pharma, pricing

The impasse over access to Vertex’s Orkambi for cystic fibrosis patients in England and Wales has revealed the cracks in …
Feature

Gilead subsidiary Kite Pharma to open CAR-T manufacturing facility in Maryland

April 29, 2019 Manufacturing and Production, Sales and Marketing CAR-T, Gilead, Manufacturing Facility, Maryland, kite pharma

Gilead Sciences subsidiary Kite Pharma has announced plans to open a new CAR-T manufacturing facility in Frederick County, Maryland (US). …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

April 26, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Aduro Biotech, Cancer, GSK, ICR, J&J, JJ, Novartis, Sandoz, pharma

The Institute for Cancer Research (ICR) called for new measures to increase the speed with which patients in the UK …
News
richard_saynor

Senior GSK exec Richard Saynor revealed as new Sandoz CEO

April 26, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Novartis has seen a major leadership change within its business, as the company announced that senior GlaxoSmithKline exec Richard Saynor …
Appointment

Interactions with the Agencies During Drug Development

April 25, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cambridge, NDA, drug development

 NDA would like to invite you to join  Professor Steffen Thirstrup, Director NDA Advisory Board, formerly Division Head at the Danish Medicines …
News
Press release
richard_saynor

Senior GSK exec Richard Saynor revealed as new Sandoz CEO

April 25, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Sandoz, appointment, pharma

Novartis has seen a major leadership change within its business, as the company announced that senior GlaxoSmithKline exec Richard Saynor …
News

Working Life: Dr Todd Hobbs, Vice President and Chief Medical Officer, Novo Nordisk

April 24, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, Working Life, feature, pharma

Novo Nordisk’s VP and CMO discusses his leap from family medicine into the pharma industry, his biggest achievements, and how …
Feature
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026